Literature DB >> 9259582

Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.

F H Guo1, K Uetani, S J Haque, B R Williams, R A Dweik, F B Thunnissen, W Calhoun, S C Erzurum.   

Abstract

Human respiratory epithelium expresses inducible nitric oxide synthase (iNOS) continuously in vivo, however mechanisms responsible for maintenance of expression are not known. We show that IFNgamma is sufficient for induction of iNOS in primary human airway epithelial cells (HAEC) in vitro, and IL-4 potentiates IFNgamma-induced iNOS expression in HAEC through stabilization of iNOS mRNA. IFNgamma/IL-4- induced iNOS expression in HAEC was delayed in onset and prolonged with expression up to 1 wk. Removal of overlying culture media resulted in loss of expression, while transfer of conditioned media induced iNOS mRNA in other HAEC. IFNgamma and IL-4 stimulation activated STAT1 and STAT6 in HAEC, but conditioned media transfer to HAEC produced even higher levels of STAT1 activation than achieved by direct addition of cytokines. Although cytokine induction of iNOS was dependent on new protein synthesis, conditioned media induction of iNOS in HAEC was not. Further, removal of overlying culture media from cells at different times after cytokine stimulation demonstrated that mediator synthesis and/or secretion important for induction and maintenance of iNOS occurs early after cytokine stimulation. In conclusion, a combination of IFNgamma/ IL-4, which occurs naturally in the lung epithelial lining fluid, leads to maintenance of iNOS expression in human airway epithelium through production of soluble mediators and stabilization of mRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259582      PMCID: PMC508255          DOI: 10.1172/JCI119598

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

2.  Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte.

Authors:  I G Charles; R M Palmer; M S Hickery; M T Bayliss; A P Chubb; V S Hall; D W Moss; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

3.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.

Authors:  C Walker; E Bode; L Boer; T T Hansel; K Blaser; J C Virchow
Journal:  Am Rev Respir Dis       Date:  1992-07

4.  Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.

Authors:  Z Dong; X Qi; K Xie; I J Fidler
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

5.  Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells.

Authors:  D C Look; S R Rapp; B T Keller; M J Holtzman
Journal:  Am J Physiol       Date:  1992-07

6.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

Authors:  L Kobzik; D S Bredt; C J Lowenstein; J Drazen; B Gaston; D Sugarbaker; J S Stamler
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

7.  Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4.

Authors:  H Kotanides; N C Reich
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

Review 8.  Measurement of nitric oxide in biological models.

Authors:  S Archer
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

9.  Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma.

Authors:  M Cembrzynska-Nowak; E Szklarz; A D Inglot; J A Teodorczyk-Injeyan
Journal:  Am Rev Respir Dis       Date:  1993-02

10.  Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids.

Authors:  A R Sousa; R N Poston; S J Lane; J A Nakhosteen; T H Lee
Journal:  Am Rev Respir Dis       Date:  1993-06
View more
  52 in total

1.  Proteomic method identifies proteins nitrated in vivo during inflammatory challenge.

Authors:  K S Aulak; M Miyagi; L Yan; K A West; D Massillon; J W Crabb; D J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.

Authors:  T J Kelley; H L Elmer
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma.

Authors:  D Sampath; M Castro; D C Look; M J Holtzman
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 5.  Nitric oxide metabolism in asthma pathophysiology.

Authors:  Sudakshina Ghosh; Serpil C Erzurum
Journal:  Biochim Biophys Acta       Date:  2011-06-21

6.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

7.  IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice.

Authors:  Timothy B Oriss; Mahesh Raundhal; Christina Morse; Rachael E Huff; Sudipta Das; Rachel Hannum; Marc C Gauthier; Kathryn L Scholl; Krishnendu Chakraborty; Seyed M Nouraie; Sally E Wenzel; Prabir Ray; Anuradha Ray
Journal:  JCI Insight       Date:  2017-05-18

8.  Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Authors:  W Gerald Teague; Brenda R Phillips; John V Fahy; Sally E Wenzel; Anne M Fitzpatrick; Wendy C Moore; Annette T Hastie; Eugene R Bleecker; Deborah A Meyers; Stephen P Peters; Mario Castro; Andrea M Coverstone; Leonard B Bacharier; Ngoc P Ly; Michael C Peters; Loren C Denlinger; Sima Ramratnam; Ronald L Sorkness; Benjamin M Gaston; Serpil C Erzurum; Suzy A A Comhair; Ross E Myers; Joe Zein; Mark D DeBoer; Anne-Marie Irani; Elliot Israel; Bruce Levy; Juan Carlos Cardet; Wanda Phipatanakul; Jonathan M Gaffin; Fernando Holguin; Merritt L Fajt; Shean J Aujla; David T Mauger; Nizar N Jarjour
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-31

9.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.

Authors:  Suzy A A Comhair; Weiling Xu; Sudakshina Ghosh; Frederik B J M Thunnissen; Alexandru Almasan; William J Calhoun; Allison J Janocha; Lemin Zheng; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.